L-4,5-二氢乳清酸 | 5988-19-2
中文名称:
L-4,5-二氢乳清酸
英文名称:
L-Dihydroorotic acid
CAS No.:
5988-19-2
分子式:
C5 H6 N2 O4
分子量:
158.1121
名称和标识符
MDL
MFCD00085339
InChIKey
UFIVEPVSAGBUSI-REOHCLBHSA-N
Inchi
1S/C5H6N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h2H,1H2,(H,9,10)(H2,6,7,8,11)/t2-/m0/s1
SMILES
O([H])C([C@]1([H])C([H])([H])C(N([H])C(N1[H])=O)=O)=O
别名信息
- 中文别名 -
L-4,5-二氢乳清酸
(S)-2,6-二氧代六氢-4-嘧啶羧酸
L-氢化乳清酸
核苷酸
酪蛋白磷酸肽
核苷酸,L-4,5-二氢乳清酸
核糖核酸(酵母)RNA
鸟苷磷酸二钠盐(GMP)
腺苷-5-磷酸(AMP)
- 英文别名 -
(S)-2,6-Dioxohexahydropyrimidine-4-carboxylic acid
L-4,5-Dihydroorotic acid~(S)-(+)-2,6-Dioxohexahydro-4-pyrimidinecarboxylic acid
L-Dihydroorotic acid
L-Hydroorotic Acid
L-4,5-dihydroorotic acid
(S)-2,6-Dioxohexahydro-4-pyrimidinecarboxylic acid
L-4
[
"L-4",
"5-Dihydroorotic acid"
]
L-dihydroorotate
(S)-dihydroorotic acid
Dihydro-L-orotic acid
(S)-dihydroorotate
Dihydroorotic acid
(4S)-2,6-dioxo-1,3-diazinane-4-carboxylic acid
L-5,6-dihydroorotic acid
(S)-4,5-Dihydroorotate
4-Pyrimidinecarboxylic acid, hexahydro-2,6-dioxo-, (4S)-
(4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE-4-CARBOXYLIC ACID
4LPL64ZNA5
(S)-4,5-dihydroorotic acid
dihydro-L-orotate
L-Dihydroo
UFIVEPVSAGBUSI-REOHCLBHSA-N
bmse000342
CS-W016211
UNII-4LPL64ZNA5
DS-1272
AM20100462
1xge
EN300-215912
2,6-Dioxohexahydro-4-pyrimidinecarboxylic acid
CHEBI:17025
L-Hydroorotic acid
SCHEMBL417324
A832525
Z1198153153
L-Dihydroorotic acid, >=99%
MFCD00085339
Hydroorotic acid, L-
Orotic acid, 4,5-dihydro-
Orotic acid, dihydro-, l-
s6111
NS00015258
Q27093197
HY-W015495
5988-19-2
DB02129
AKOS006237846
2,6-Dioxohexahydro-4-pyrimidinecarboxylic acid- (L)-
AC-23957
DTXSID30331399
C00337
B6065778-D9A6-498E-9226-03E068EAF3F9
DOR
hexahydro-2,6-dioxo-4-Pyrimidinecarboxylic acid
Q-101528
Hydroorotic acid L-form [MI]
4,5-dihydro-L-orotate
Dihydroorotate
(S)-4,5-dihydroorotate
物化性质
实验特性
LogP
-0.67330
PSA
95.50000
折射率
1.5090 (estimate)
水溶性
Soluble in water (partly), and dimethyl formamide.
沸点
283.16°C (rough estimate)
熔点
254-255 ºC (dec.)
颜色与性状
Powder
溶解性
未确定
比旋光度
+33°, c = 1 in 1% NaHCO3
密度
1.523
计算特性
精确分子量
158.03300
氢键供体数量
3
氢键受体数量
4
可旋转化学键数量
1
同位素质量
158.033
重原子数量
11
复杂度
225
同位素原子数量
0
确定原子立构中心数量
1
不确定原子立构中心数量
0
确定化学键立构中心数量
0
不确定化学键立构中心数量
0
共价键单元数量
1
疏水参数计算参考值(XlogP)
-1.5
互变异构体数量
8
表面电荷
0
拓扑分子极性表面积
95.5
海关数据
海关编码
2934999001
海关数据
中国海关编码:
2934999001
相关文献
1.
Deoiled sunflower seeds ameliorate depression by promoting the production of monoamine neurotransmitters and inhibiting oxidative stress
Xiaomeng Lu,Qi Ce,Long Jin,Jie Zheng,Mei Sun,Xue Tang,Duo Li,Jin Sun Food Funct. 2021 12 573
2.
Replacing piperidine in solid phase peptide synthesis: effective Fmoc removal by alternative bases
Giulia Martelli,Paolo Cantelmi,Chiara Palladino,Alexia Mattellone,Dario Corbisiero,Tommaso Fantoni,Alessandra Tolomelli,Marco Macis,Antonio Ricci,Walter Cabri,Lucia Ferrazzano Green Chem. 2021 23 8096
3.
Computational study of the mechanism of half-reactions in class 1A dihydroorotate dehydrogenase from Trypanosoma cruzi
Natália de Farias Silva,Jer?nimo Lameira,Cláudio Nahum Alves,Sergio Martí Phys. Chem. Chem. Phys. 2013 15 18863
4.
Insights into the mechanism of oxidation of dihydroorotate to orotate catalysed by human class 2 dihydroorotate dehydrogenase: a QM/MM free energy study
Cláudio Nahum Alves,José Rogério A. Silva,Adrian E. Roitberg Phys. Chem. Chem. Phys. 2015 17 17790
5.
Biological evaluation of quinoline derivatives as inhibitors of human dihydroorotate dehydrogenase
Jiawei Wang,Yanyan Diao,Junsheng Zhu,Shiliang Li,Zhenjiang Zhao,Honglin Li,Lili Zhu Med. Chem. Commun. 2016 7 853
6.
Towards the conversion of CO2 into optically pure N-carbamoyl-l-aspartate and orotate by an in vitro multi-enzyme cascade
Zonglin Li,Su Shen,Zhimin Li Green Chem. 2020 22 5798
7.
Towards the conversion of CO2 into optically pure N-carbamoyl-l-aspartate and orotate by an in vitro multi-enzyme cascade
Zonglin Li,Su Shen,Zhimin Li Green Chem. 2020 22 5798
8.
Synthesis, structure–activity relationship and binding mode analysis of 4-thiazolidinone derivatives as novel inhibitors of human dihydroorotate dehydrogenase
Fanxun Zeng,Tiantian Qi,Chunyan Li,Tingfang Li,Honglin Li,Shiliang Li,Lili Zhu,Xiaoyong Xu Med. Chem. Commun. 2017 8 1297
9.
Structure-based design of potent human dihydroorotate dehydrogenase inhibitors as anticancer agents
Wenlin Song,Shiliang Li,Yi Tong,Jiawei Wang,Lina Quan,Zhuo Chen,Zhenjiang Zhao,Yufang Xu,Lili Zhu,Xuhong Qian,Honglin Li Med. Chem. Commun. 2016 7 1441
10.
Structural insights into inhibition of the drug target dihydroorotate dehydrogenase by bacterial hydroxyalkylquinolines
Samantha M. Horwitz,Tamra C. Blue,Joseph A. Ambarian,Shotaro Hoshino,Mohammad R. Seyedsayamdost,Katherine M. Davis RSC Chem. Biol. 2022 3 420
与L-4,5-二氢乳清酸相关的问答
L-4,5-二氢乳清酸的沸点是多少?
「L-4,5-二氢乳清酸」5988-19-2
L-4,5-二氢乳清酸的熔点是多少?
谁能提供「L-4,5-二氢乳清酸」靠谱的价格
「1-甲基-L-4,5-二氢乳清酸」有哪些品牌?
核苷酸,L-4,5-二氢乳清酸的沸点是多少?
核苷酸,L-4,5-二氢乳清酸的熔点是多少?
「1-甲基-L-4,5-二氢乳清酸」有哪些品牌?
「1-甲基-L-4,5-二氢乳清酸」有哪些品牌?
「核苷酸,L-4,5-二氢乳清酸」5988-19-2
960化工网为您提供L-4,5-二氢乳清酸专业化合物百科信息,包括中文名,英文名,分子式,分子量,以及该化合物的CasNo.:5988-19-2,和相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等